title: Mannan-binding lectin (MBL) in women with tumours of the reproductive system.
abstract: Mannan-binding lectin (MBL) is an important factor of innate immunity contributing to the clearance of microorganisms. Recently, an antitumourigenic role of MBL has been suggested. We investigated mbl2 genotypes, MBL concentrations, and MBL-MASP-2 complex activity in patients with ovarian cancer. The expression of both mbl2 and masp-2 genes were investigated in ovarian tissue sections. Additionally, samples from patients with other malignant and benign tumours of the reproductive tract were tested. A significantly higher incidence of MBL deficiency/insufficiency-associated genotypes was found among patients with malignant disease compared to age-matched controls. Unexpectedly, no differences in median MBL level or MBL-MASP-2 complex activity were found between the groups. This was partly a reflection of higher MBL concentrations and MBL-MASP-2 activity in cancer patients compared with healthy women carrying corresponding genotypes. MBL-specific mRNA expression was detected in several normal and malignant ovarian tissues, as well as in ovarian epithelial cell lines. Intracellular staining with MBL-specific antibodies demonstrated the presence of MBL in ovarian cell lines, and in normal as well as malignant ovarian tissue sections. In contrast, MASP-2-specific mRNA expression was detected only in the ovary tissues of patients with malignant disease. No significant changes in MBL concentration during 3 months of chemotherapy were noticed. MBL was detected in ascites and in the fluid of benign ovarian cysts. Our findings may reflect anti-tumourigenic activity of MBL protein which might suggest potential therapeutic application. However, it cannot be excluded that mbl-2 mutant alleles may be in linkage disequilibrium with an unidentified tumour susceptibility gene(s).
authors.affiliation: Laboratory of Immunobiology of Infections, Centre of Medical Biology, Polish Academy of Sciences, Lodowa 106, 93-232 Łódź, Poland. aswierzko@cbm.pan.pl
authors.forename: A St
authors.initials: AS
authors.lastname: Swierzko
authors.forename: K
authors.initials: K
authors.lastname: Florczak
authors.forename: M
authors.initials: M
authors.lastname: Cedzyński
authors.forename: J
authors.initials: J
authors.lastname: Szemraj
authors.forename: D
authors.initials: D
authors.lastname: Wydra
authors.forename: L
authors.initials: L
authors.lastname: Bak-Romaniszyn
authors.forename: J
authors.initials: J
authors.lastname: Emerich
authors.forename: Z
authors.initials: Z
authors.lastname: Sułowska
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D045744:Cell Line, Tumor; D005260:Female; D005434:Flow Cytometry; D015870:Gene Expression; D020869:Gene Expression Profiling; D005838:Genotype; D006239:Haplotypes; D006801:Humans; D007150:Immunohistochemistry; D037601:Mannose-Binding Lectin / Q000032:analysis / Q000378:metabolism*; D050606:Mannose-Binding Protein-Associated Serine Proteases / Q000032:analysis / Q000378:metabolism; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D037601:Mannose-Binding Lectin; C105296:MASP2 protein, human; D050606:Mannose-Binding Protein-Associated Serine Proteases